10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 364 filers reported holding 10X GENOMICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $431,681 | +2.2% | 10,465 | +38.4% | 0.01% | 0.0% |
| Q2 2023 | $422,262 | +8.1% | 7,562 | +8.0% | 0.01% | +12.5% |
| Q1 2023 | $390,530 | +38.3% | 7,000 | -9.7% | 0.01% | +33.3% |
| Q4 2022 | $282,410 | -48.7% | 7,750 | -59.8% | 0.01% | -50.0% |
| Q3 2022 | $550,000 | -40.5% | 19,299 | -5.6% | 0.01% | -33.3% |
| Q2 2022 | $925,000 | -42.2% | 20,442 | -2.7% | 0.02% | -28.0% |
| Q1 2022 | $1,599,000 | -51.0% | 21,015 | -4.0% | 0.02% | -46.8% |
| Q4 2021 | $3,261,000 | +15.1% | 21,889 | +12.5% | 0.05% | +9.3% |
| Q3 2021 | $2,832,000 | -7.3% | 19,454 | +24.6% | 0.04% | -4.4% |
| Q2 2021 | $3,056,000 | +58.0% | 15,607 | +46.1% | 0.04% | +50.0% |
| Q1 2021 | $1,934,000 | +200.3% | 10,685 | +134.8% | 0.03% | +172.7% |
| Q4 2020 | $644,000 | – | 4,551 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |